Leucine-rich repeat flightless-interacting protein 2 (LRRFIP2) is a cytoplasmic protein known to play essential roles in various cellular processes, including immune regulation, inflammation, and cancer progression. LRRFIP2 contains leucine-rich repeats (LRRs), which are protein-protein interaction motifs often involved in mediating signal transduction pathways. Through its interactions with other proteins, LRRFIP2 participates in the regulation of innate immune responses, particularly in the context of viral infections and inflammatory signaling. Additionally, LRRFIP2 has been implicated in the modulation of cellular proliferation and apoptosis, suggesting its involvement in the control of cell fate decisions.
The activation of LRRFIP2 is mediated by several signaling pathways and cellular stimuli. One mechanism of activation involves its phosphorylation by various protein kinases, such as IKKε and TBK1, in response to viral infections or inflammatory stimuli. Phosphorylation of LRRFIP2 leads to conformational changes that enhance its interaction with downstream signaling components, thereby amplifying immune responses and promoting inflammatory signaling. Additionally, LRRFIP2 activation can be regulated by post-translational modifications, such as ubiquitination, which modulate its stability and cellular localization. Furthermore, LRRFIP2 activity may be influenced by its association with other proteins or regulatory factors, which can either enhance or suppress its function depending on the cellular context. Overall, understanding the mechanisms underlying LRRFIP2 activation provides insights into its diverse roles in cellular physiology and pathology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
LPS can stimulate immune cells and activate NF-kB, potentially influencing LRRFIP2's associated pathways. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
As a GSK3β inhibitor, LiCl affects Wnt signaling, potentially indirectly activating LRRFIP2. | ||||||